January 11, 2021
Avantor® to Report Fourth Quarter and Full Year 2020 Earnings and Host Earnings Call on Wednesday, February 3, 2021
January 11, 2021
Avantor® Announces Preliminary Fourth Quarter Unaudited Revenues and Estimated Free Cash Flow
December 17, 2020
Avantor® Sets Science in Motion for Goodness with Donations and Grants to Community-Based Organizations
December 14, 2020
Avantor® to Present at the 39th Annual J.P. Morgan Healthcare Conference
November 23, 2020
Avantor® to Participate at the Evercore ISI 3rd Annual HealthCONx Virtual Conference
November 19, 2020
Avantor® Opens New Biorepository Facility in Europe to Support Growing Demand for Scientific Research and Clinical Trial Sample Storage
November 11, 2020
Avantor® to Present at the Jefferies Virtual London Healthcare Conference
November 05, 2020
Avantor® Announces Pricing of Upsized Secondary Offering
November 04, 2020
Avantor® Announces Secondary Offering of 71,339,001 Shares of Common Stock
November 02, 2020
Avantor® Discusses Cell & Gene Therapy Production Trends Through the Lens of COVID-19
October 30, 2020
Avantor® Announces Upsizing and Pricing of Offering of €650.0 Million of Senior First Lien Notes
October 28, 2020
Avantor® Announces Offering of Senior First Lien Notes
October 27, 2020
Avantor® Reports Third Quarter 2020 Results and Announces Time Change for Earnings Call
October 23, 2020
Avantor® Announces Preliminary Third Quarter Unaudited Revenues
October 21, 2020
Avantor® Declares Dividend on Mandatory Convertible Preferred Stock
October 21, 2020
Avantor® Discusses Supply Chain Readiness at 2020 World Vaccine Congress Europe
October 08, 2020
Avantor's General Counsel Justin Miller Honored as "Legend in Law" by The Burton Awards Program
October 02, 2020
Avantor® to Report Third Quarter Earnings and Host Earnings Call on Wednesday, October 28, 2020
September 22, 2020
Avantor® Appoints Frederic Vanderhaegen Executive Vice President, Americas and Europe
September 01, 2020
Avantor® to Present at the Morgan Stanley Virtual Healthcare Conference
August 31, 2020
Avantor® to Present at the 2020 Wells Fargo Virtual Healthcare Conference
August 20, 2020
Avantor® Announces Pricing of Upsized Secondary Offering
August 19, 2020
Avantor® Announces Secondary Offering of 38,500,000 Shares of Common Stock
August 10, 2020
Avantor Announces Credit Rating Upgrade by S&P Global Ratings
July 29, 2020
Avantor® Reports Second Quarter 2020 Results
July 21, 2020
Avantor® Declares Dividend on Mandatory Convertible Preferred Stock
July 07, 2020
Avantor® Announces Upsizing and Pricing of Offering of $2.0 Billion Equivalent of Senior Notes
July 07, 2020
Avantor® Announces Preliminary Second Quarter 2020 Unaudited Revenue
July 07, 2020
Avantor® Announces Offering of Senior Notes
July 01, 2020
Avantor® to Report Second Quarter Earnings and Host Earnings Call on Wednesday, July 29, 2020
June 30, 2020
Avantor® Expands Life Sciences Innovation Center to Address Bioprocessing Needs in Protein Science, Monoclonal Antibodies (mAbs), Cell and Gene Therapy
June 23, 2020
Avantor® Named to Fortune 500 List
May 26, 2020
Avantor® Announces Closing of Secondary Offering and Full Exercise of Underwriters' Option to Purchase Additional Shares
May 22, 2020
Avantor Announces Credit Rating Upgrade by Fitch Ratings
May 20, 2020
Avantor® Announces Pricing of Secondary Offering
May 18, 2020
Avantor® Announces Secondary Offering of 45,000,000 Shares of Common Stock
May 06, 2020
Avantor to Present at the Virtual Bank of America Securities 2020 Healthcare Conference
April 29, 2020
Avantor Reports First Quarter 2020 Results
April 23, 2020
Avantor® and the Avantor Foundation Provide Support to Address Coronavirus (COVID-19) Pandemic
April 21, 2020
Avantor® Declares Dividend on Mandatory Convertible Preferred Stock
April 03, 2020
Avantor® to Report First Quarter 2020 Earnings and Host Earnings Call on Wednesday, April 29, 2020
March 23, 2020
Avantor® Appoints Tommy Thomas as Vice President, Investor Relations
March 18, 2020
Avantor® Launches New Protein A Chromatography Resin - PROchievA - that Provides Supply Chain Flexibility and Improves Downstream Purification Performance for Monoclonal Antibodies (mAbs) Production
February 18, 2020
Avantor® to Participate in Cowen and Company's 40th Annual Health Care Conference
February 07, 2020
Avantor Reports Fourth Quarter and Full-Year 2019 Results
January 24, 2020
Avantor® to Report Fourth Quarter and Full Year 2019 Earnings and Host Earnings Call on Friday, February 7
January 21, 2020
Avantor® Declares Dividend on Mandatory Convertible Preferred Stock
January 02, 2020
Avantor® to Participate in the J.P. Morgan Healthcare Conference
December 11, 2019
Avantor® Opens Innovation and Customer Support Center in Shanghai to Boost Biopharmaceutical Innovation in China
November 25, 2019
Avantor® to Participate in the Evercore ISI HealthCONx Conference
November 06, 2019
Avantor® and NIBRT Collaborate to Advance Bioprocessing by Addressing Downstream Bottlenecks in Monoclonal Antibodies (mAbs) Production
November 05, 2019
Avantor Reports Third Quarter 2019 Results